Burlingame, CA, United States of America

John Woolfrey


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Unveiling the Innovations of John Woolfrey: Pioneer in Coagulation Disorder Treatment

Introduction: John Woolfrey is a distinguished inventor based in Burlingame, CA (US), renowned for his groundbreaking work in the field of pharmaceuticals. With a keen focus on developing novel compounds to combat coagulation disorders, Woolfrey has made significant contributions to the medical community.

Latest Patents: Woolfrey's most notable patent is for "Benzamide Inhibitors of Factor Xa." This patent showcases his innovative approach towards creating benzamide compounds with exceptional activity against mammalian Factor Xa. These compounds have demonstrated efficacy in preventing and treating coagulation disorders both in vitro and in vivo.

Career Highlights: Woolfrey is a key figure at Millennium Pharmaceuticals Limited, where he channels his expertise in pharmaceutical research and development. His dedication to advancing the field of medicine has led to the successful filing of multiple patents, with a sharp focus on improving patient outcomes.

Collaborations: Throughout his career, Woolfrey has collaborated with esteemed professionals in the field, including Bing-Yan Zhu and Penglie Zhang. Together, they have synergized their expertise to push the boundaries of pharmaceutical innovation and bring new treatment options to those in need.

Conclusion: In conclusion, John Woolfrey stands as a beacon of innovation in the realm of coagulation disorder treatment. His pioneering work, coupled with his collaborative efforts, underscores his commitment to enhancing healthcare solutions. Woolfrey's inventive spirit continues to inspire and drive advancements in the pharmaceutical industry, promising a brighter future for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…